Intratympanic steroids for idiopathic sudden sensorineural hearing loss

Annals of Otology, Rhinology and Laryngology

Volumn 116, Issue 4 I, 2007, Pages 253-256

  Fitzgerald, Dennis C ^a,c   McGuire, John F ^b  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Idiopathic sudden sensorineural hearing loss; Intratympanic steroids

Indexed keywords

METHYLPREDNISOLONE; STEROID;

ADULT; ARTICLE; AUDIOMETRY; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; FEMALE; HUMAN; IDIOPATHIC DISEASE; LOGISTIC REGRESSION ANALYSIS; MALE; OTALGIA; PERCEPTION DEAFNESS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUDDEN DEAFNESS; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 34247473448     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940711600405     Document Type: Article

References (26)

1. Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol 1980;106:772-6.
2. Uri N, Doweck I, Cohen-Kerem R, Greenberg E. Acyclovir in the treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2003;128:544-9.
3. Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999;109(suppl 9).
4. Chandrasekhar SS, Rubinstein RY, Kwartler JA, et al. Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg 2000;122:521-8.
5. Chandrasekhar SS. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol 2001;22:18-23.
6. Nadel DM. The use of systemic steroids in otolaryngology. Ear Nose Throat J 1996;75:502-5, 509-12.
7. Himeno C, Komeda M, Izumikawa M, et al. Intra-cochlear administration of dexamethasone attenuates aminoglycoside ototoxicity in the guinea pig. Hear Res 2002;167:61-70.
8. Shoji F, Miller AL, Mitchell A, Yamasoba T, Altschuler RA, Miller JM. Differential protective effects of neurotrophins in the attenuation of noise-induced hair cell loss. Hear Res 2000;146:134-42.
9. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995;113:181-5.
10. Rarey KE, Curtis LM. Receptors for glucocorticoids in the human inner ear. Otolaryngol Head Neck Surg 1996;115:38-41.
11. Erichsen S, Stierna P, Bagger-Sjoback D, et al. Distribution of Na,K-ATPase is normal in the inner ear of a mouse with a null mutation of the glucocorticoid receptor. Hear Res 1998;124:146-54.
12. Kopke RD, Hoffer ME, Wester D, O'Leary MJ, Jackson RL. Targeted topical steroid therapy in sudden sensorineural hearing loss. Otol Neurotol 2001;22:475-9.
13. Balyan FR, Taibah A, De Donato G, et al. Titration streptomycin therapy in Meniere's disease: long-term results. Otolaryngol Head Neck Surg 1998;118:261-6.
14. Shirwany NA, Seidman MD, Tang W. Effects of transtympanic injection of steroids on cochlear blood flow, auditory sensitivity, and histology in the guinea pig. Am J Otol 1998; 19:230-5.
15. Lee JH, Marcus DC. Nongenomic effects of corticosteroids on ion transport by stria vascularis. Audiol Neurootol 2002;7:100-6.
16. Ryan AF, Pak K, Low W, et al. Immunological damage to the inner ear: current and future therapeutic strategies. Adv Otorhinolaryngol 2002;59:66-74.
17. Barbara M, Attanasio G, Petrozza V, Modesti A, Filipo R. The endolymphatic sac as the immunocompetent organ of the inner ear. Ann N Y Acad Sci 1997;830:243-52.
18. Yang GS, Song HT, Keithley EM, Harris JP. Intratympanic immunosuppressives for prevention of immune-mediated sensorineural hearing loss. Am J Otol 2000;21:499-504.
19. Gacek RR, Gacek MR. Vestibular neuronitis. Am J Otol 1999;20:553-4.
20. Zadeh MH, Storper IS, Spitzer JB. Diagnosis and treatment of sudden-onset sensorineural hearing loss: a study of 51 patients. Otolaryngol Head Neck Surg 2003;128:92-8.
21. Alexiou C, Arnold W, Fauser C, et al. Sudden sensorineural hearing loss: does application of glucocorticoids make sense? Arch Otolaryngol Head Neck Surg 2001;127:253-8.
22. Selivanova OA, Gouveris H, Victor A, Amadee RG, Mann W. Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Meniere's-associated sudden sensorineural hearing loss. Otol Neurotol 2005;26:890-5.
23. Slattery WH, Fisher LM, Iqbal Z, Friedman RA, Liu N. Intratympanic steroid injection for treatment of idiopathic sudden hearing loss. Otolaryngol Head Neck Surg 2005;133:251-9.
24. Gianoli GJ, Li JC. Transtympanic steroids for treatment of sudden hearing loss, Otolaryngol Head Neck Surg 2001;125: 142-6.
25. Lefebvre PP, Staecker H. Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: a pilot study. Acta Otolaryngol (Stockh) 2002; 122:698-702.
26. Banerjee A, Parnes LS. Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss. Otol Neurotol 2005;26:878-81.